Institut de Cancérologie Hématologie Universitaire de Saint Etienne (iCHUSE)

The medical center is at the forefront of hematology and oncology research, focusing on innovative treatments for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) with a specific emphasis on FLT3 mutations. The center's research aims to enhance the efficacy of combination therapies involving gilteritinib and midostaurin alongside traditional chemotherapy.

• Acute Myeloid Leukemia (AML)
• Myelodysplastic Syndrome (MDS)
• FLT3 Mutation Therapies

By integrating cutting-edge research with clinical applications, the center is pioneering advancements in personalized medicine for patients with complex hematological malignancies.

Specializing in the treatment of severe cardiac inflammation, the medical center is conducting pivotal research on the use of high dose pulse intravenous corticosteroid therapy for patients with complicated acute myocarditis. This research is crucial in developing new therapeutic strategies that aim to improve patient outcomes by reducing the incidence of severe cardiac events.

• Acute Myocarditis
• Corticosteroid Therapy
• Cardiac Inflammation Management

The center's work in cardiology is instrumental in advancing the understanding and treatment of inflammatory heart conditions, offering hope for improved quality of life for affected patients.